| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 147.489 | 80 |
| GSM780708 | Untreated after 4 days (C2_1) | 137.207 | 79 |
| GSM780709 | Untreated after 4 days (C3_1) | 114.65 | 77 |
| GSM780719 | Untreated after 4 days (C1_2) | 163.5 | 81 |
| GSM780720 | Untreated after 4 days (C2_2) | 155.656 | 81 |
| GSM780721 | Untreated after 4 days (C3_2) | 143.266 | 80 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 129.775 | 79 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 140.462 | 80 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 147.795 | 80 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 141.963 | 80 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 160.061 | 81 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 165.057 | 82 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 124.356 | 78 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 142.974 | 80 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 130.594 | 79 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 147.336 | 80 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 134.417 | 79 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 135.11 | 79 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 166.008 | 82 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 148.32 | 80 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 150.865 | 80 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 149.429 | 80 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 169.445 | 82 |